Description
Dactus 3 mg is an oral antidiabetic medication manufactured by ACME Laboratories Ltd., primarily used to manage Type 2 diabetes mellitus. It contains Glimepiride, a second-generation sulfonylurea that works by stimulating the release of insulin from the pancreas and enhancing the body's sensitivity to insulin. This dual action helps lower blood glucose levels, especially when diet and exercise alone are insufficient. Dactus 3 mg is typically taken once daily with the first main meal to reduce the risk of hypoglycemia. The dosage may be adjusted based on individual blood glucose monitoring, with the usual maintenance dose ranging from 1 to 4 mg per day. It can be used alone or in combination with other antidiabetic agents like metformin or insulin, depending on the patient's needs. However, combining Dactus with insulin may increase the risk of hypoglycemia. Patients should be monitored regularly, especially during the initial weeks of treatment, to adjust the dosage appropriately and ensure optimal glycemic control.
.webp)
.jpeg)
.png)
.jpeg)
.jpeg)
.png)
.webp)
.webp)
.png)
Change Language